Cold-EEZE(R) Helps Consumers Navigate Cold Season
February 24 2010 - 8:30AM
Marketwired
The Quigley Corporation (NASDAQ: QGLY), manufacturer and
distributor of the clinically proven cold remedy, Cold-EEZE®,
announced today the release of a new online video series aimed at
educating the public about staying healthy during the cold season.
The series, reported and hosted by physician and medical
correspondent Dr. Bob Arnot, offers critical information about
treating, beating and even preventing the common cold. The videos
will be available to millions of viewers on a variety of targeted
Internet outlets.
Each year millions of people contract the common cold. This cold
season has been particularly difficult because of the H1N1 and
seasonal flu outbreaks. The common cold weakens the immune system
leaving the sufferer at risk for developing advanced infections.
The videos offer information to the public that can increase the
chances of remaining healthy.
"The fact that we make a product that has been clinically proven
to reduce the duration and severity of the common cold, certainly
helped drive our decision to underwrite the series," noted Ted
Karkus, CEO of The Quigley Corporation. "We believe the information
has great value to anyone at risk for the common cold, which of
course, is everyone."
"More than 80% of what the public knows about medicine they know
from television news style stories," said Dr. Arnot. "These are
clear and easy to comprehend. We're delighted to follow Ted Karkus'
far sighted leadership role in bringing these to an Internet
audience which far exceeds the numbers possible on TV and with
valuable expert knowledge that can improve the health of tens of
millions of viewers."
The videos explore ways to engage in early treatment of the
common cold as well as research relating to prevention and symptom
reduction. Dr. Bob Arnot hosts and reports from Vermont, Utah and
New Hampshire with reviews of some of the latest scientific
literature and interviews with healthcare professionals.
For more information about Cold-EEZE, please visit our website
at www.coldeeze.com.
About The Quigley Corporation
The Quigley Corporation (NASDAQ: QGLY)
(http://www.Quigleyco.com) is a diversified natural health medical
science company. Its Cold Remedy segment is a leading marketer and
manufacturer of the Cold-EEZE® family of lozenges and sugar free
tablets clinically proven to significantly reduce the severity and
duration of the common cold. Cold-EEZE® customers include leading
national wholesalers and distributors, as well as independent and
chain food, drug and mass merchandise stores and pharmacies. The
Quigley Corporation has several wholly owned subsidiaries including
Quigley Manufacturing Inc., which consists of an FDA approved
facility to manufacture Cold-EEZE® lozenges and fulfill other
contract manufacturing opportunities, and Quigley Pharma, Inc.
(http://www.QuigleyPharma.com), which conducts research in order to
develop and commercialize a pipeline of patented botanical and
naturally derived potential prescription drugs.
Forward-Looking Statements
Certain statements in this press release are "forward-looking
statements" within the meaning of the Private Securities Litigation
Reform Act of 1995 and involve known and unknown risk,
uncertainties and other factors that may cause the Company's actual
performance or achievements to be materially different from the
results, performance or achievements expressed or implied by the
forward-looking statement. Factors that impact such forward-looking
statements include, among others, changes in worldwide general
economic conditions, changes in interest rates, government
regulations, and worldwide competition.
Media Relations: The Lexicomm Group Wendi Tush Email
Contact (212) 794-4531 Lindsey Gardner Email Contact (570) 479-4895
Investor Contact: Ted Karkus Chairman and CEO The Quigley
Corporation 215.345.0919 x 0
The Quigley (MM) (NASDAQ:QGLY)
Historical Stock Chart
From Jul 2024 to Aug 2024
The Quigley (MM) (NASDAQ:QGLY)
Historical Stock Chart
From Aug 2023 to Aug 2024